| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| CODE KENNETH REAY | Chief Science Officer, Director | 14921 CHESTNUT ST., WESTMINSTER | /s/ John R. Browning, attorney-in-fact | 17 Nov 2025 | 0001370684 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BLGO | Common Stock | Award | $50,201 | +313,754 | +1.2% | $0.1600 | 25,751,505 | 14 Nov 2025 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The shares issued are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. |
| F2 | Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share). |
| F3 | Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation. |